Clinical Trial Update: First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin [Phase 3]

View source ↗

Summary

Phase 3 trial evaluates first-line treatment with necitumumab plus gemcitabine and cisplatin in stage IV squamous non-small cell lung cancer; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)
• Necitumumab (Portrazza) (necitumumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-06-27